Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer (PFE) is facing hurdles due to weakened demand for its products and pipeline diversification challenges. Nevertheless, the company exhibits long-term potential through strategic acquisitions. Given this scenario, what course of action should be considered ahead of the upcoming earnings release? Read more to find out.

StockNews.com

More Than 150 Infants, Pregnant Women Given Incorrect RSV Vaccine, CDC Says

According to reports, there have been 25 cases of accidental administration of Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines to children below two and 128 cases of mistaken administration of the GSK RSV vaccine (Arexvy) to pregnant women.

Medical Daily

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

The Guardian - UK

CES 2024: How Tony Stark Can Save Pro AV (and Other Trends)

Artificial intelligence, electrification, hydrogen power, sustainability, human security, and mobility dominated the show floor.

AVNetwork

DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace

Opponents of diversity programs are increasingly banking on an 1866 civil rights law meant to protect Black people from economic exclusion as a way to challenge corporate diversity and equity policies as well as funding to Black-owned businesses

The Independent UK

As legal challenges mount, some companies retool diversity and inclusion programs

Conservative advocates have filed a growing number of legal challenges, encouraged by the Supreme Court’s June ruling ending affirmative action in college admissions

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

FDA allows imports of French syphilis drug alternate during US penicillin shortage

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

Fortune

Boosters recommended as new COVID variant rips through states

It comes as the ACT plans to stop recording COVID numbers.

The Canberra Times

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Inverse

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

Top News

‘Scientific nonsense’: experts dismiss Florida official’s Covid vaccine remarks

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

Kiplinger

Drugmakers to Hike Prices on 500 Drugs Soon — Report

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

Barchart

Where Will Pfizer Stock Be in 1 Year?

PFE is a beaten-down healthcare stock that trades at a discount to consensus price target estimates. Is Pfizer stock a good buy right now?

Newcastle Herald

New normal? What COVID will look like in 2024

Should the government do more to support people with long-COVID?

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Men Up review: Viagra drama is a sweet tale of bonding in the face of shared misfortune

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

StockNews.com

Pfizer (PFE) 2024 Preview: What to Expect From the Pharma Stock?

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….

The Independent UK

Inside Men Up – the Viagra drama determined to get men talking

The writer and stars of the brilliant BBC One film tell Katie Rosseinsky about delving into the origins of a drug that is so often associated with a punchline, but has irrevocably changed many people’s lives

International Business Times

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

The Conversation

mRNA COVID vaccines make 'unintended proteins' – we've discovered how to fix this problem

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

Evening Standard

Men Up: what's the true story behind the BBC's new drama about the first Viagra trials in Wales?

In 2021, impotence affected as many as 16.5 million men in the UK; 50 per cent of the male population. But how many of them talked about it? To their friends, even to their partners? Men have always been tight-lipped about their problems – health problems even more so, and those…

Barchart

I’ve Got 5 Stocks and 5 DTEs: Which Call Should I Buy?

Wednesday’s unusual options activity had multiple stocks with two or more calls expiring on the same day. Five stocks caught my interest. Only one of the calls is worth buying.

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.